Sharon Cload, Vice President, Molecular Discovery Technologies

Sharon Cload, Ph.D

Vice President

Molecular Discovery Technologies

Biography

Sharon Cload serves as vice president of molecular discovery technologies at Bristol-Myers Squibb. There, she leads a multi-functional team that delivers designs, reagents and molecular characterization data across drug modalities and therapeutic areas.

 

As head of her group, Sharon oversees all aspects of scientific exchange to ensure they flow smoothly. Sharon and her group are instrumental in helping drive early discovery in the lab. For example, by being able to engineer proteins, discover antibodies and generate antigens, their aim is to help solve problems that may bottleneck or disrupt the discovery process.  

 

“We partner with the biologists that have a specific problem they want to address, and help develop molecules that have the particular properties needed. We provide the engineering perspective, they provide the biology perspective, and that teamwork is really gratifying.”

 

Sharon joined Bristol-Myers Squibb in 2008. Previously, she spent time at various biotech companies in the Boston/Cambridge area. She received her Ph.D. in bio-organic chemistry from Yale University and is an inventor on over a dozen patents. 

Interests and Expertise

Sharon’s interest in the life sciences began at a young age. She realized her aptitude for chemistry in high school and decided to pursue a career that would allow her to put her natural aptitude for problem solving to good use.

 

“It’s my job to make sure that the right people are working behind the right lab bench, operating as a team to make a difference. By doing this correctly, we can create a self-motivated community that is excited about acting on new ideas,” she says.

 

Outside of the lab, Sharon’s main passion is running. As a West Coast native transplanted to Cambridge at the beginning of her corporate career, Sharon is now fully ensconced in her environment. She’s even completed the Boston Marathon four times. For Sharon, the parallel between running the lab and long-distance running is too great to be ignored. Like a marathon, drug discovery requires endurance, dedication and drive; but the success that comes with crossing the finish line makes it all worth it.